No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.

This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.

In the high-stakes market for COVID-19 vaccines, it is worth considering what motivates a private firm to relinquish valuable IP rights.

What if you have a great idea for a new technology, but never actually create it, test it, or determine that it works? Is that patentable?

Legal claims could be made by patients who argue that they have suffered because they have been unable to access care because of COVID-19 NHS restrictions.

By John Tingle The independent regulator for health and social care in England, the Quality Care Commission (CQC) has recently published its annual report on the real-time state of health and social care in England. It analyses trends, shares examples of outstanding, good, and poor health care care practices. It provides a true, unabashed account…
